W

WuXi XDC Cayman Inc
HKEX:2268

Watchlist Manager
WuXi XDC Cayman Inc
HKEX:2268
Watchlist
Price: 24.8 HKD -5.16% Market Closed
Market Cap: 29.7B HKD
Have any thoughts about
WuXi XDC Cayman Inc?
Write Note

WuXi XDC Cayman Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

WuXi XDC Cayman Inc
Capital Expenditures Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
W
WuXi XDC Cayman Inc
HKEX:2268
Capital Expenditures
-ÂĄ539.4m
CAGR 3-Years
-117%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Capital Expenditures
-ÂĄ4.6B
CAGR 3-Years
0%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Capital Expenditures
-ÂĄ2.3B
CAGR 3-Years
-6%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Capital Expenditures
-ÂĄ3.5B
CAGR 3-Years
21%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Capital Expenditures
-ÂĄ359m
CAGR 3-Years
-8%
CAGR 5-Years
-31%
CAGR 10-Years
-25%
Genscript Biotech Corp
HKEX:1548
Capital Expenditures
-$177.1m
CAGR 3-Years
-9%
CAGR 5-Years
-20%
CAGR 10-Years
N/A

See Also

What is WuXi XDC Cayman Inc's Capital Expenditures?
Capital Expenditures
-539.4m CNY

Based on the financial report for Dec 31, 2023, WuXi XDC Cayman Inc's Capital Expenditures amounts to -539.4m CNY.

What is WuXi XDC Cayman Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-117%

Over the last year, the Capital Expenditures growth was -168%. The average annual Capital Expenditures growth rates for WuXi XDC Cayman Inc have been -117% over the past three years .

Back to Top